Infectious Diseases in Obstetrics and Gynecology / 2011 / Article / Tab 4

Clinical Study

Chlamydia trachomatis and Mycoplasma genitalium Plasma Antibodies in Relation to Epithelial Ovarian Tumors

Table 4

Clinical characteristics of women with type II tumors and plasma samples drawn 1.3–5.1 years prior to diagnosis.

Clinical characteristicsType II tumors with prospective plasma samples ( )

Age, y62 (56–69)
Menarche, y14 (12–16)
Menopause, y50 (41–60)
Parity 3 (0–5)
 0 children 2 (29%)
 ≥3 children 4 (57%)
Oral contraceptive pill use ≥1 yeara 2 (33%),
Past or current HRT use 2 (29%)
Past or current smoking 2 (29%)
History of PID 2 (29%)
BMI26 (20–31)
 Serous ovarian cancer 4
 Mixed epithelial ovarian cancer 1
 Undifferentiated ovarian cancer 1

Values are presented as medians and range (minimum and maximum values of age, menarche, menopause, parity, and BMI); or number and percentage of patients in each group (0 children, ≥3 children, oral contraceptive pill use ≥1 year, past or current HRT use, past or current smoking, history of PID).
HRT: hormone replacement therapy; PID: pelvic inflammatory disease; BMI: body mass index; SSPC: Serous Surface Papillary Carcinoma.
aMissing data in one case.